anonymous
Guest
anonymous
Guest
First of many layoffs.
First of many layoffs.
First of many layoffs.
Based on our ex-employee-friend's spending copious amounts of time obsessing over the supposed impending failure of Alimera, I think it is fair to guess that s/he was fired for lack of productivity.
Got to say Firing Kaba the Hut was one of the best decisions Rick has ever made.Dead Man Walking. Kaba Out!
Great to hear that a deal with a Chinese distributor has been agreed for iluvien. This will open up further opportunities for sure.
Wow...you're such a smart guy. You'd think these billion dollar companies would do some research and figure out what you have. Oh.....maybe they have done their research and you're just a disgruntled ex-employee that doesn't know crap.
The wet AMD market is driving sales of anti vegf drugs, those patients are prioritised in clinics as they can loose vision very quickly, so sales are holding well. It’s the patients with DME that are not attending clinics that’s why steroid sales are down.It like this. When we can sell to a distributor its called "an increase in sales". When you have no more distributors to sell to, sales drop off. Iluvien is designed to keep patients from having to return for monthly injections, so you would think during the pandemic numbers of units would increase. Genentec's numbers are up as well as other VEGF companies. Funny how are numbers continiue to drop?
You continue to make my point. You're smarter than all these international distributors that keep buying our product and they don't even realize they have a warehouse full that hasn't moved in 5 years. Shhhh...stop telling them our corporate strategy....they haven't figured it out after 5 years on the market. And certainly don't let the new Asian company figure out they they will buy millions that will never move out of their warehouses. I'm sure they did no market research before making their deal.It like this. When we can sell to a distributor its called "an increase in sales". When you have no more distributors to sell to, sales drop off. Iluvien is designed to keep patients from having to return for monthly injections, so you would think during the pandemic numbers of units would increase. Genentec's numbers are up as well as other VEGF companies. Funny how are numbers continiue to drop?
Wow...you're such a smart guy. You'd think these billion dollar companies would do some research and figure out what you have. Oh.....maybe they have done their research and you're just a disgruntled ex-employee that doesn't know crap.
You continue to make my point. You're smarter than all these international distributors that keep buying our product and they don't even realize they have a warehouse full that hasn't moved in 5 years. Shhhh...stop telling them our corporate strategy....they haven't figured it out after 5 years on the market. And certainly don't let the new Asian company figure out they they will buy millions that will never move out of their warehouses. I'm sure they did no market research before making their deal.